Comments

Novo Nordisk

Q: What sector and industry does Novo Nordisk (NVO) operate in?

Novo Nordisk is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.

NVONYSE

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$87.65

0.130.15%

At close: -

$87.81

0.160.18%

After Hours: Jan 3, 7:58 PM EDT

Novo Nordisk (NVO) Forecast

News Earnings Novo Nordisk (NVO) Options Guidance Dividends Analyst Ratings Insider Trades Government Trades Short Interest

Overview Rating

Good

Technicals Analysis

0100

Financials Analysis

0100

Novo Nordisk (NYSE:NVO) Stock Quotes, Forecast and News Summary

Novo Nordisk Stock (NYSE: NVO) stock price, news, charts, stock research, profile.

Open	$87.49
Close	$87.65
Volume / Avg.	3.77M / 6.25M
Day Range	$87.34 - $88.19
52 Wk Range	81.50 - 148.15
Market Cap	$389.99B
P/E Ratio	29.59
Dividend Yield	1.65%
Exchange	NYSE
RSI	39
Short Interest	0.15%
Days to Cover	1

Recent News

Don't Buy Weight-Loss Medication From Unauthorized Sources, UK Health Agency Warns About Risks

The MHRA warns against buying weight-loss medicines illegally, emphasizing health risks and the need for prescriptions from licensed professionals to ensure safety.

Vandana Singh

US Employer Health Costs To Rise In 2025 Fueled By Weight Loss: Report

Eli Lilly's Zepbound is challenging Wegovy in the obesity market, while U.S. health care costs are set to rise 9% in 2025, driven by specialty drugs and inflation.

Vandana Singh

Why 2024 Was Great for Stocks—and Why 2025 Could Be Even Better

It has been a strong year for stocks, and the best may be yet to come. With only one trading day left in 2024, the S&P 500 Index is up approximately 23%. However, as investors look back on the year,

MarketBeat

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Aug 24

Sep 24

Oct 24

Nov 24

Dec 24

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$87.49
Close	$87.65
Volume / Avg.	3.77M / 6.25M
Day Range	$87.34 - $88.19
52 Wk Range	81.50 - 148.15
Market Cap	$389.99B
P/E Ratio	29.59
Dividend Yield	1.65%
Exchange	NYSE
RSI	39
Short Interest	0.15%
Days to Cover	1

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

How do I buy Novo Nordisk (NVO) stock?

You can purchase shares of Novo Nordisk (NYSE:NVO) through any online brokerage.

View our list of the best stock brokerages

Who are Novo Nordisk (NVO) competitors?

Other companies in Novo Nordisk’s space includes: Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Verona Pharma (NASDAQ:VRNA), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).

What is the forecast, or price target, for Novo Nordisk (NVO) stock?

Novo Nordisk has a consensus price target of $116.57.

What is the current price for Novo Nordisk (NVO)?

The stock price for Novo Nordisk (NYSE: NVO) is $87.81 last updated January 3, 2025 at 7:58 PM EST.

Does Novo Nordisk (NVO) pay a dividend?

A quarterly cash dividend of 2.50 per share of Class A Common Stock. The quarterly cash dividend was payable on April 2, 2012 to stockholders of record on March 22, 2012.

When is Novo Nordisk (NYSE:NVO) reporting earnings?

Novo Nordisk’s Q4 earnings are confirmed for Wednesday, February 5, 2025.

Is Novo Nordisk (NVO) going to split?

There is no upcoming split for Novo Nordisk.

What sector and industry does Novo Nordisk (NVO) operate in?

Novo Nordisk is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.